Phase 3 Clinical Trials With Primary Completion Dates in June 2020

This is a list of Phase 3 trials with primary completion dates in June 2020 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker tool. It includes information on all clinical trials for publicly traded companies, screenable by stock symbol, market cap, disease, completion date, and phase.

The primary completion date is the date that the final subject was examined or received an intervention for the purposes of final collection of data for the primary outcome. It provides advance notice that a company will be announcing trial results in the near future.

SymbolCompanyPrimary Completion DatePhaseNCT IDTitle
ABSCFAB Science S.A.2020-06-01Phase 3NCT01694277Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib
AKBAAkebia Therapeutics, Inc.2020-06-01Phase 3NCT02680574Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
AKBAAkebia Therapeutics, Inc.2020-06-01Phase 3NCT02648347Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
AKCAAkcea Therapeutics, Inc.2020-06-01Phase 3NCT02658175The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
AMAGAMAG Pharmaceuticals, Inc.2020-06-01Phase 3NCT03297216Improving Pregnancy Outcomes With Progesterone
APLSApellis Pharmaceuticals, Inc.2020-06-01Phase 3NCT04085601A Study to Evaluate the Efficacy and Safety of APL-2 in Patients With PNH
APREAprea Therapeutics, Inc.2020-06-01Phase 3NCT03745716APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)
BCDABioCardia, Inc.2020-06-01Phase 3NCT02438306CardiAMP™ Heart Failure Trial
BYSIBeyondSpring Inc.2020-06-01Phase 3NCT03102606Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
CANFCan-Fite BioPharma Ltd.2020-06-01Phase 3NCT02647762CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis
CATBCatabasis Pharmaceuticals, Inc.2020-06-01Phase 3NCT03703882Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
CHHLChina Holdings, Inc.2020-06-01Phase 3NCT03660059A Study to Assess Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)
CPHIChina Pharma Holdings, Inc.2020-06-01Phase 3NCT03660059A Study to Assess Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)
ENDPEndo International plc2020-06-01Phase 3NCT02687451Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
HESGHealth Sciences Group, Inc.2020-06-01Phase 3NCT02703389Improving Knowledge Translation Upon Emergency Department Discharge
HESGHealth Sciences Group, Inc.2020-06-01Phase 3NCT03740048A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease
HRTXHeron Therapeutics, Inc.2020-06-01Phase 3NCT03907176Herniorrhaphy Study for Opioid Elimination
INOInovio Pharmaceuticals, Inc.2020-06-01Phase 3NCT03185013REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
IONSIonis Pharmaceuticals, Inc.2020-06-01Phase 3NCT02658175The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
KNSAKiniksa Pharmaceuticals, Ltd.2020-06-01Phase 3NCT03737110RHAPSODY Phase 3 Study to Assess the Efficacy and Safety of Rilonacept Treatment in Subjects With Recurrent Pericarditis
KPTIKaryopharm Therapeutics Inc.2020-06-01Phase 3NCT03110562Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
MRDHMeridian Holdings, Inc.2020-06-01Phase 3NCT01877837Stem Cell Transplantation for Sickle Cell Anemia
RDUSRadius Health, Inc.2020-06-01Phase 3NCT03512262Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)
SNGXSoligenix, Inc.2020-06-01Phase 3NCT03237325DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
STSASatsuma Pharmaceuticals, Inc.2020-06-01Phase 3NCT03901482A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine